These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 16650874)

  • 21. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathogenesis of cognitive impairment in multiple sclerosis].
    Nakahara J
    Rinsho Shinkeigaku; 2014; 54(12):1063-5. PubMed ID: 25672710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive dysfunction 24-31 years after isolated optic neuritis.
    Nilsson P; Rorsman I; Larsson EM; Norrving B; Sandberg-Wollheim M
    Mult Scler; 2008 Aug; 14(7):913-8. PubMed ID: 18573827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive impairment and structural brain damage in benign multiple sclerosis.
    Rovaris M; Riccitelli G; Judica E; Possa F; Caputo D; Ghezzi A; Bertolotto A; Capra R; Falautano M; Mattioli F; Martinelli V; Comi G; Filippi M
    Neurology; 2008 Nov; 71(19):1521-6. PubMed ID: 18815387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thalamic atrophy and cognition in multiple sclerosis.
    Houtchens MK; Benedict RH; Killiany R; Sharma J; Jaisani Z; Singh B; Weinstock-Guttman B; Guttmann CR; Bakshi R
    Neurology; 2007 Sep; 69(12):1213-23. PubMed ID: 17875909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.
    Benedict RH; Bruce JM; Dwyer MG; Abdelrahman N; Hussein S; Weinstock-Guttman B; Garg N; Munschauer F; Zivadinov R
    Arch Neurol; 2006 Sep; 63(9):1301-6. PubMed ID: 16966509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive dysfunction in primary progressive multiple sclerosis: a neuropsychological and MRI study.
    Ukkonen M; Vahvelainen T; Hämäläinen P; Dastidar P; Elovaara I
    Mult Scler; 2009 Sep; 15(9):1055-61. PubMed ID: 19556313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.
    Peterson JW; Bö L; Mörk S; Chang A; Trapp BD
    Ann Neurol; 2001 Sep; 50(3):389-400. PubMed ID: 11558796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.
    Ramasamy DP; Benedict RH; Cox JL; Fritz D; Abdelrahman N; Hussein S; Minagar A; Dwyer MG; Zivadinov R
    J Neurol Sci; 2009 Jul; 282(1-2):47-54. PubMed ID: 19201003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability.
    Charil A; Dagher A; Lerch JP; Zijdenbos AP; Worsley KJ; Evans AC
    Neuroimage; 2007 Jan; 34(2):509-17. PubMed ID: 17112743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extensive hippocampal demyelination in multiple sclerosis.
    Geurts JJ; Bö L; Roosendaal SD; Hazes T; Daniëls R; Barkhof F; Witter MP; Huitinga I; van der Valk P
    J Neuropathol Exp Neurol; 2007 Sep; 66(9):819-27. PubMed ID: 17805012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Orbitofrontal dysfunction in multiple sclerosis: Iowa Gambling Task].
    García-Molina A; Rodríguez Rajo P; Vendrell Gómez P; Junqué i Plaja C; Roig-Rovira T
    Psicothema; 2008 Aug; 20(3):445-9. PubMed ID: 18674441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extensive subpial cortical demyelination is specific to multiple sclerosis.
    Junker A; Wozniak J; Voigt D; Scheidt U; Antel J; Wegner C; Brück W; Stadelmann C
    Brain Pathol; 2020 May; 30(3):641-652. PubMed ID: 31916298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of attention related structures in multiple sclerosis patients.
    Nebel K; Wiese H; Seyfarth J; Gizewski ER; Stude P; Diener HC; Limmroth V
    Brain Res; 2007 Jun; 1151():150-60. PubMed ID: 17397807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic resonance evidence of cortical onset of multiple sclerosis.
    Calabrese M; Gallo P
    Mult Scler; 2009 Aug; 15(8):933-41. PubMed ID: 19667021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The blood-brain barrier in cortical multiple sclerosis lesions.
    van Horssen J; Brink BP; de Vries HE; van der Valk P; Bø L
    J Neuropathol Exp Neurol; 2007 Apr; 66(4):321-8. PubMed ID: 17413323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The limits of functional reorganization in multiple sclerosis.
    Schoonheim MM; Geurts JJ; Barkhof F
    Neurology; 2010 Apr; 74(16):1246-7. PubMed ID: 20404304
    [No Abstract]   [Full Text] [Related]  

  • 38. Cortical deficits in multiple sclerosis on the basis of subcortical lesions.
    Jeffery DR; Absher J; Pfeiffer FE; Jackson H
    Mult Scler; 2000 Feb; 6(1):50-5. PubMed ID: 10694846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis.
    Dineen RA; Vilisaar J; Hlinka J; Bradshaw CM; Morgan PS; Constantinescu CS; Auer DP
    Brain; 2009 Jan; 132(Pt 1):239-49. PubMed ID: 18953055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of cortical lesions is dependent on choice of slice thickness in patients with multiple sclerosis.
    Dolezal O; Dwyer MG; Horakova D; Havrdova E; Minagar A; Balachandran S; Bergsland N; Seidl Z; Vaneckova M; Fritz D; Krasensky J; Zivadinov R
    Int Rev Neurobiol; 2007; 79():475-89. PubMed ID: 17531855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.